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Much of the recent advances in functional genomics owe to developments in next-generation sequencing
technology, which has contributed to the exponential increase of genomic data available for different
human disease and population samples. With functional sequencing assays available to query both the tran-
scriptome and the epigenome, annotation of the non-coding, regulatory genome is steadily improving and
providing means to interpret the functional consequences of genetic variants associated with human com-
plex traits. This has highlighted the need to better understand the normal variation in various cellular pheno-
types, such as epigenetic modifications, and their transgenerational inheritance. In this review, we discuss
different aspects of epigenetic variation in the context of DNA sequence variation and its contribution to com-
plex phenotypes.
INTRODUCTION
Genome-wide genetic information for different human popula-
tions and phenotypes is becoming increasingly abundant due
to the efforts of projects such as the 1000 Genomes project
(1) and the recent wave of genome-wide association studies
(GWASs) in human complex traits (2). Due to exceptionally
large study samples, thousands of genetic variants, primarily
single-nucleotide polymorphisms (SNPs), have been asso-
ciated with diseases and other trait phenotypes with very
good estimates of the effect size and the significance of the
effects. While this is a major milestone in human genetics,
an important component of these studies, i.e. the understand-
ing and interpretation of the function of the associated var-
iants, is still largely lacking. It has become evident that most
of these variants are regulatory rather than coding, which
has emphasized the urgent need for better functional annota-
tion of the human genome. To address this, large-scale
studies such as the ENCODE project (3) were set out to iden-
tify and catalog all functional elements in the human and other
mammalian genomes, and while these efforts have provided a
tremendous amount of new information, we are still far from
understanding the default function and interplay or such ele-
ments in different tissues and developmental stages. In this
context, trying to evaluate the impact of specific nucleotide
changes on the functionality of such elements is a challenge.
Thus, we are still a long way from sequencing a single
genome and inferring its deviation from the ‘standard’
genome or cellular function.
A key method to disentangle the functionality of genetic
variants is to directly measure their molecular effects. This
can be done by analyzing DNA sequence variation for associ-
ation with different intermediate phenotypes at the cellular
level. This approach helps to reduce the indirect link
between a genetic variant and a whole-organism phenotype
(such as a disease) to more direct links between these variants
and their intermediate effects. There are many assays to study
different types of molecular and cellular phenotypes (4), but
some of the most popular, well-understood and well-
developed ones measure epigenetic modifications, i.e. chem-
ical modifications of DNA or chromatin. Such modifications
are often viewed as proxies to regulatory changes occurring
at a genomic region and are therefore highly informative of
local molecular effects. Epigenetic modifications can result
from either genetic variants that influence the epigenetic
state of a genomic region or environmental effects that are
stored and remembered in the form of epigenetic modifica-
tions. In fact, it is now well accepted that much of the
memory of our body of past environmental exposures and be-
havioral effects is mediated by epigenetic changes in the
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relevant cell types and tissues (5). This is of great importance
as it follows from this that much of the information on human
phenotypic variability and disease risk can be accessed direct-
ly by assaying appropriate cells from our body. Therefore,
understanding of epigenetic variation is crucial to the under-
standing of both genome function and environmental effects
on the individual genomes of our cells.
In this review, we will discuss the technological and meth-
odological advances that have transformed the study of epi-
genetic variation. We will touch on the genetic and
environmental causes of epigenetic variation and their inter-
play, as well as the recently introduced concept of epigenome-
wide association studies (EWASs). We will discuss what such
studies can tell us about causality of epigenetic factors, and
what they cannot.
TECHNOLOGICAL ADVANCES ARE ENABLING
NEW APPROACHES
According to the current view, genetic information carried by
the DNA sequence is embedded in a complex and dynamic
‘cloud’ of chromatin and associated proteins such as transcrip-
tion factors that define the readout of the DNA sequence. The
backbone of this cloud, loosely defined as the epigenome, is
made up of nucleosomes, the building blocks of chromatin.
Nucleosomes in turn consist of DNA wrapped around
histone proteins, which are subject to many different types
of covalent modifications (reviewed, for example, in 6) and
whose functional consequences are incompletely understood.
Methylation of both DNA and RNA molecules is considered
an epigenetic mechanism, as well as the silencing effects
mediated by the expanding pool of non-coding RNAs of dif-
ferent lengths, which have been shown to regularly interact
with chromatin (7). Finally, it will not be sufficient much
longer to study the genome simply as a linear structure, as in-
creasing evidence suggests complex three-dimensional inter-
actions between distant genomic loci as well as the genome
and the nuclear lamina (8,9). It has recently been shown that
such interactions are closely related to different epigenetic
domains (10). Understanding the interplay of these organiza-
tional layers of our genome is one of the main aims of
current epigenomic research.
Histone modifications, which typically affect the tails of the
core histone molecules protruding out of the nucleosome, can
be divided roughly into activating and repressive modifica-
tions, based on their effects on transcription. The number of
possible modifications and modifiable sites in humans is
huge, and new ones are continuously being discovered.
Thus, with research and antibody production lagging behind,
our knowledge of the functional role of individual histone
modifications remains superficial at best. Studying histone
modifications and other epigenetic markers in a combinatorial
manner across the genome to define different chromatin states
and domains and their interactions with the DNA molecule is
likely to be the most powerful approach to elucidate their
functions, as has already been demonstrated by several
studies (see, for example, 11,12).
Much of the recent advances in epigenomic studies owe
to developments in next-generation sequencing (NGS)
technology, which has transformed the type and amount of in-
formation that can be extracted with traditional techniques
such as chromatin immunoprecipitation or bisulphate sequen-
cing in DNA methylation studies. The NGS platform has also
enabled the rapid development of new assays (for example,
Gro-seq) (13) and the scale-up of pre-existing methods such
as chromosome conformation capture (3C)-based techniques,
which can now be performed globally, genome-wide (Hi-C)
(14). Significant contributions to method development have
also been made by large, collaborative research projects like
the ENCODE (3). As the resolution of most functional NGS
assays approaches a single base pair, allele-specific readout
genome-wide, they have become directly relevant to genetic
mapping studies of complex traits, most of which struggle to
interpret the functional consequences of the identified DNA
variants. Also, importantly, NGS has helped to bring epige-
nomics as a field conceptually closer to other ‘omics’ fields,
by improving the reproducibility and precision of results.
GENETIC VARIATION AND THE EPIGENOME
The word ‘epigenome’ has resulted in a number of misconcep-
tions. While the Greek prefix ‘epi-’ states that the effects or
modifications are ‘on’ the genome, epigenetics has frequently
been misunderstood as effects that are independent of the
genome. In fact, statements such as ‘it is not the genome, it
is the epigenome’ are not uncommon in the field. Although
such classification might appear purely philosophical, it has
a profound impact on the approaches taken to study phenotyp-
ic variation in humans. Instead of viewing genetics and epi-
genetics as two conflicting areas that one needs to take sides
on, it is much more productive to view them as two highly
connected concepts. For example, it is known that epigenetic
variation at a given genomic locus can be directly caused by
variation in the DNA sequence. On the other hand, epigenetic
changes triggered by environmental effects can act as modi-
fiers to genetic variants. In one of the first studies of genetic
variation affecting epigenetic properties, family-based cell
lines were assayed for DNaseI hypersensitivity (DNaseI HS),
a proxy for open chromatin structure, and binding of
CCCTC-binding factor (CTCF) (15). The study demonstrated
that 65% of the variation in CTCF binding is heritable due
to transmitted DNA sequence variation, and the same trend
was observed for DNaseI HS sites. In this example, epigenetic
variation can simply be seen as a molecular phenotype.
Epigenetic variation has been proposed as an explanation
for the large amount of missing heritability in complex traits
(16,17), which has created a lot of confusion. Epigenetic vari-
ation can undoubtedly contribute to disease risk and cause
phenotypic variability, but for it to contribute to complex
trait heritability independent of genetic variation one has to
assume that variable epigenetic modifications are transmitted
from one generation to the next intact, i.e. without DNA vari-
ation acting as the determining and transmitting factor. While
there is some evidence that such modifications are present in
other mammals (18), evidence from human populations is
lacking. Such effects in humans are likely to exist, but the in-
ability to detect them to date suggests that they are not
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abundant enough to significantly contribute to the heritability
of complex traits.
The combination of genetic and epigenetic information can
also provide direct links of causality of DNA sequence vari-
ation. A recent study assayed DNase I hypersensitivity in 70
cell lines from a population sample and reported thousands
of genetic variants affecting the level of chromatin accessibil-
ity (DNase I sensitivity quantitative trait loci, dsQTL) (19).
They observed that 16% of their dsQTLs affected the expres-
sion of nearby genes (i.e. were also classified as expression
quantitative trait loci, eQTL), and subsequently estimated
that as many as 55% of eQTLs influence expression vari-
ation through changes in chromatin accessibility. Other
studies have linked DNA sequence variation to methylation
and gene expression in a similar manner (20). While the link
between the three measurements seems to some extent easy
to derive (for example, SNP to methylation to expression),
care should be taken when making conclusions of the direc-
tionality of effects (Fig. 1). Contrary to a genetic association
where the direction of the effect is by definition from the
SNP to the phenotype, an association between an epigenetic
mark and a phenotype, in the absence of further information
such as longitudinal measurements, provides no evidence as
to which one is cause and which is effect. Multi-dimensional
studies that link DNA sequence variation, epigenetic modifica-
tions, and whole organism phenotypes are, and will be, very
important for the detailed characterization of human genetic
functional variation. They will also contribute towards the es-
tablishment of a genomic blueprint, which will enable the
functional and phenotypic interpretation of personalized
genomes in the near future.
NON-GENETIC EPIGENETIC VARIATION
The epigenetic layout of the genome is influenced by both
genetic and environmental factors. Epigenetic variation can
be directly linked to genetic variation (15), and environmental
effects, such as those experienced in utero, can be mediated by
epigenetic modifications (5,21). As the heritability of complex
phenotypes is never 100% and they thus include a significant
non-genetic, potentially epigenetic component, the ability to
separate between DNA sequence mediated and non-genetic
epigenetic variation will be important. It is also important to
identify and distinguish between stable and dynamic epigenet-
ic changes, as dynamic modifications are the most likely
proxies for environmental effects.
It has been proposed that epigenomic equivalents of
GWASs, i.e. EWASs, could be used to measure the proportion
of phenotypic variance between any two individuals that is
explained by epigenetic variation (22). In practice, this
would mean analyzing suitable epigenetic markers, most
plausibly DNA methylation levels, in a large collection of
cases and controls for association to a given complex trait
(Fig. 2). The biggest challenge of EWASs is likely to be dis-
tinguishing between effects mediated by genetic variants
versus truly epigenetic properties, as well as the causality
versus consequentiality of the identified effects. Thus, an
EWAS discovery-stage study sample should ideally consist
of monozygotic (MZ) twins, to ensure identification of epigen-
etic variation independent of the genetic background that
could then be replicated in a more traditional case–control
sample or, better still, a prospective cohort that would help
to distinguish between the cause and consequence of the epi-
genomic variant (22).
Such approach was taken by Rakyan et al. (23) who identi-
fied DNA methylation variable positions significantly corre-
lated with type 1 diabetes (T1D) in discordant MZ twins.
The authors first confirmed the finding in a separate set of
T1D-discordant twins and, using further case–control study
samples, were able to show that the identified variants
precede disease diagnosis. Such rigorous efforts to distinguish
the temporal origin of any trait-associated epigenetic variants
will be needed, if the problem of causality is to be resolved.
However, for most phenotypes, it will not be trivial to accu-
mulate such study samples, especially if any other biological
material than DNA is required.
A few other examples of EWASs have also been published.
Breitling et al. (24) measured DNA methylation at CpG sites
across the genome from 177 current, former and non-smokers
and identified a single site, which showed genome-wide sig-
nificant association with lowered methylation levels in heavy
Figure 1. Directionality of molecular effects.
Figure 2. Design of genomic studies. DNA sequence variants can have direct
effects on whole-organism phenotypes (e.g. disease status) and/or multiple
intermediate, cellular phenotypes (e.g. gene expression, DNA methylation,
transcription factor binding and histone modifications). Such effects can be
analyzed with GWASs and by mapping QTLs. If association of intermediate
phenotypes with the whole-organism phenotype is analyzed (e.g. with
EWASs), the distinction between cause and consequence cannot be estab-
lished without additional information.
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smokers. The finding was replicated in an independent sample
of 328 people. In another study (25), Bell et al. studied 172
twins and identified differentially methylated regions asso-
ciated with age and other aging-related phenotypes. Whilst
in the first study the possible influence of genetic variation
was not considered, the second study suggested that in a
small subset of genes, DNA methylation might mediate
genetic association with age-related phenotypes, highlighting
the difficulty in interpreting the causality and directionality
of epigenetic variation.
Overall, given the dynamic nature of epigenetic variation, it
is hard to estimate whether comparisons of epigenetic pheno-
types in a case–control setting will be any more useful than
such comparisons of gene expression data in complex trait
phenotypes. Unlike GWASs, all epigenomic studies face the
problem of tissue specificity, and until more tissues relevant
to the phenotypes in question become available for analysis
in sufficient numbers, the conclusions that can be made from
these studies remain limited. Much like gene expression,
which as a phenotype is not well suited for an EWAS, analysis
of epigenetic variation is likely to be most successful when
combined with the analysis of genetic variants (i.e. QTL
mapping).
CONCLUSIONS AND FUTURE PERSPECTIVES
In the next few years, our understanding of the multiple layers
of genomic information is likely to improve significantly, as
new functional sequencing assays will be developed and
applied to larger numbers of samples and tissues. Similarly
to the data released by the International HapMap Project
(26) and later by the 1000 Genomes Project (1), when such
functional reference datasets will become available to the
field, the interpretation, follow-up and clinical relevance of
GWAS results will take a big leap forward. The understanding
of the direct consequences of genetic variants to human
biology will result in better and more comprehensive interpret-
ation of personal genomes, a step that is likely to transform
biomedical research and medical practice.
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